ESSILORLUXOTTICA (EL.PA) Fundamental Analysis & Valuation

EPA:EL • FR0000121667

210 EUR
-3 (-1.41%)
Last: Mar 11, 2026, 05:36 PM

This EL.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to EL. EL was compared to 65 industry peers in the Health Care Equipment & Supplies industry. EL has an average financial health and profitability rating. EL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. EL.PA Profitability Analysis

1.1 Basic Checks

  • EL had positive earnings in the past year.
  • In the past year EL had a positive cash flow from operations.
  • EL had positive earnings in each of the past 5 years.
  • In the past 5 years EL always reported a positive cash flow from operatings.
EL.PA Yearly Net Income VS EBIT VS OCF VS FCFEL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

1.2 Ratios

  • EL has a Return On Assets of 3.62%. This is comparable to the rest of the industry: EL outperforms 50.77% of its industry peers.
  • Looking at the Return On Equity, with a value of 5.95%, EL is in line with its industry, outperforming 43.08% of the companies in the same industry.
  • EL has a Return On Invested Capital (4.96%) which is in line with its industry peers.
Industry RankSector Rank
ROA 3.62%
ROE 5.95%
ROIC 4.96%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EL.PA Yearly ROA, ROE, ROICEL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of EL (8.13%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of EL has grown nicely.
  • EL's Operating Margin of 11.85% is in line compared to the rest of the industry. EL outperforms 52.31% of its industry peers.
  • In the last couple of years the Operating Margin of EL has grown nicely.
  • The Gross Margin of EL (59.69%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of EL has remained more or less at the same level.
Industry RankSector Rank
OM 11.85%
PM (TTM) 8.13%
GM 59.69%
OM growth 3Y-2.08%
OM growth 5Y30.97%
PM growth 3Y-2.57%
PM growth 5Y69.02%
GM growth 3Y-1.64%
GM growth 5Y0.64%
EL.PA Yearly Profit, Operating, Gross MarginsEL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

4

2. EL.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EL is destroying value.
  • There is no outstanding debt for EL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EL.PA Yearly Shares OutstandingEL.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
EL.PA Yearly Total Debt VS Total AssetsEL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 3.04 indicates that EL is not in any danger for bankruptcy at the moment.
  • EL has a better Altman-Z score (3.04) than 61.54% of its industry peers.
  • EL has a debt to FCF ratio of 3.82. This is a good value and a sign of high solvency as EL would need 3.82 years to pay back of all of its debts.
  • EL's Debt to FCF ratio of 3.82 is in line compared to the rest of the industry. EL outperforms 60.00% of its industry peers.
  • EL has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
  • EL has a Debt to Equity ratio of 0.24. This is in the better half of the industry: EL outperforms 64.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 3.82
Altman-Z 3.04
ROIC/WACC0.63
WACC7.9%
EL.PA Yearly LT Debt VS Equity VS FCFEL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

  • EL has a Current Ratio of 0.99. This is a bad value and indicates that EL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EL has a worse Current ratio (0.99) than 81.54% of its industry peers.
  • A Quick Ratio of 0.70 indicates that EL may have some problems paying its short term obligations.
  • The Quick ratio of EL (0.70) is worse than 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.7
EL.PA Yearly Current Assets VS Current LiabilitesEL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. EL.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 0.90% over the past year.
  • The Earnings Per Share has been growing by 30.65% on average over the past years. This is a very strong growth
  • The Revenue has been growing slightly by 7.48% in the past year.
  • Measured over the past years, EL shows a quite strong growth in Revenue. The Revenue has been growing by 14.58% on average per year.
EPS 1Y (TTM)0.9%
EPS 3Y2.19%
EPS 5Y30.65%
EPS Q2Q%-0.64%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y5.17%
Revenue growth 5Y14.58%
Sales Q2Q%9.45%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.77% on average over the next years. This is quite good.
  • Based on estimates for the next years, EL will show a quite strong growth in Revenue. The Revenue will grow by 9.20% on average per year.
EPS Next Y12.36%
EPS Next 2Y13.55%
EPS Next 3Y14.08%
EPS Next 5Y9.77%
Revenue Next Year11.21%
Revenue Next 2Y10.81%
Revenue Next 3Y10.71%
Revenue Next 5Y9.2%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EL.PA Yearly Revenue VS EstimatesEL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
EL.PA Yearly EPS VS EstimatesEL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

2

4. EL.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 30.66 indicates a quite expensive valuation of EL.
  • EL's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 26.25, EL is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 27.28, the valuation of EL can be described as expensive.
  • EL's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of EL to the average of the S&P500 Index (24.39), we can say EL is valued inline with the index average.
Industry RankSector Rank
PE 30.66
Fwd PE 27.28
EL.PA Price Earnings VS Forward Price EarningsEL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EL is on the same level as its industry peers.
  • EL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 25.83
EV/EBITDA 16.88
EL.PA Per share dataEL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EL does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as EL's earnings are expected to grow with 14.08% in the coming years.
PEG (NY)2.48
PEG (5Y)1
EPS Next 2Y13.55%
EPS Next 3Y14.08%

6

5. EL.PA Dividend Analysis

5.1 Amount

  • EL has a Yearly Dividend Yield of 1.85%. Purely for dividend investing, there may be better candidates out there.
  • In the last 3 months the price of EL has falen by -24.49%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • EL's Dividend Yield is a higher than the industry average which is at 1.01.
  • Compared to an average S&P500 Dividend Yield of 1.82, EL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.85%

5.2 History

  • The dividend of EL has a limited annual growth rate of 4.50%.
Dividend Growth(5Y)4.5%
Div Incr Years3
Div Non Decr Years4
EL.PA Yearly Dividends per shareEL.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • 23.63% of the earnings are spent on dividend by EL. This is a low number and sustainable payout ratio.
  • EL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP23.63%
EPS Next 2Y13.55%
EPS Next 3Y14.08%
EL.PA Yearly Income VS Free CF VS DividendEL.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
EL.PA Dividend Payout.EL.PA Dividend Payout, showing the Payout Ratio.EL.PA Dividend Payout.PayoutRetained Earnings

EL.PA Fundamentals: All Metrics, Ratios and Statistics

ESSILORLUXOTTICA

EPA:EL (3/11/2026, 5:36:15 PM)

210

-3 (-1.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)04-22
Inst Owners28.44%
Inst Owner ChangeN/A
Ins Owners32.07%
Ins Owner ChangeN/A
Market Cap97.29B
Revenue(TTM)28.49B
Net Income(TTM)2.31B
Analysts85.45
Price Target331.09 (57.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.85%
Yearly Dividend2.56
Dividend Growth(5Y)4.5%
DP23.63%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.9%
PT rev (3m)0.17%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.23%
EPS NY rev (3m)-5.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.44%
Revenue NY rev (3m)3.77%
Valuation
Industry RankSector Rank
PE 30.66
Fwd PE 27.28
P/S 3.41
P/FCF 25.83
P/OCF 18.39
P/B 2.5
P/tB N/A
EV/EBITDA 16.88
EPS(TTM)6.85
EY3.26%
EPS(NY)7.7
Fwd EY3.67%
FCF(TTM)8.13
FCFY3.87%
OCF(TTM)11.42
OCFY5.44%
SpS61.5
BVpS83.94
TBVpS-4.05
PEG (NY)2.48
PEG (5Y)1
Graham Number113.74
Profitability
Industry RankSector Rank
ROA 3.62%
ROE 5.95%
ROCE 6.52%
ROIC 4.96%
ROICexc 5.33%
ROICexgc 34.55%
OM 11.85%
PM (TTM) 8.13%
GM 59.69%
FCFM 13.22%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.08%
OM growth 5Y30.97%
PM growth 3Y-2.57%
PM growth 5Y69.02%
GM growth 3Y-1.64%
GM growth 5Y0.64%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 3.82
Debt/EBITDA 1.46
Cap/Depr 48.99%
Cap/Sales 5.35%
Interest Coverage 250
Cash Conversion 81.55%
Profit Quality 162.68%
Current Ratio 0.99
Quick Ratio 0.7
Altman-Z 3.04
F-Score7
WACC7.9%
ROIC/WACC0.63
Cap/Depr(3y)49.88%
Cap/Depr(5y)48.88%
Cap/Sales(3y)5.71%
Cap/Sales(5y)5.75%
Profit Quality(3y)150.08%
Profit Quality(5y)168.44%
High Growth Momentum
Growth
EPS 1Y (TTM)0.9%
EPS 3Y2.19%
EPS 5Y30.65%
EPS Q2Q%-0.64%
EPS Next Y12.36%
EPS Next 2Y13.55%
EPS Next 3Y14.08%
EPS Next 5Y9.77%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y5.17%
Revenue growth 5Y14.58%
Sales Q2Q%9.45%
Revenue Next Year11.21%
Revenue Next 2Y10.81%
Revenue Next 3Y10.71%
Revenue Next 5Y9.2%
EBIT growth 1Y-2.12%
EBIT growth 3Y2.98%
EBIT growth 5Y50.07%
EBIT Next Year73.26%
EBIT Next 3Y27.8%
EBIT Next 5Y19.38%
FCF growth 1Y12.35%
FCF growth 3Y5.46%
FCF growth 5Y10.35%
OCF growth 1Y8.56%
OCF growth 3Y3.42%
OCF growth 5Y12.38%

ESSILORLUXOTTICA / EL.PA FAQ

What is the ChartMill fundamental rating of ESSILORLUXOTTICA (EL.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to EL.PA.


What is the valuation status for EL stock?

ChartMill assigns a valuation rating of 3 / 10 to ESSILORLUXOTTICA (EL.PA). This can be considered as Overvalued.


What is the profitability of EL stock?

ESSILORLUXOTTICA (EL.PA) has a profitability rating of 5 / 10.


What is the valuation of ESSILORLUXOTTICA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ESSILORLUXOTTICA (EL.PA) is 30.66 and the Price/Book (PB) ratio is 2.5.


Can you provide the dividend sustainability for EL stock?

The dividend rating of ESSILORLUXOTTICA (EL.PA) is 6 / 10 and the dividend payout ratio is 23.63%.